| Attribute |
Value |
| 52 Week Change |
-0.06561679 |
| Address1 |
Wagistrasse 14 |
| All Time High |
32.04 |
| All Time Low |
3.32 |
| Ask |
4.26 |
| Ask Size |
4 |
| Average Daily Volume10 Day |
2,050 |
| Average Daily Volume3 Month |
1,265 |
| Average Volume |
1,265 |
| Average Volume10Days |
2,050 |
| Beta |
0.688 |
| Bid |
3.91 |
| Bid Size |
1 |
| Book Value |
1.8457018 |
| City |
Schlieren |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
Switzerland |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
3.56 |
| Current Ratio |
7.274 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
3.71 |
| Day Low |
3.56 |
| Debt To Equity |
5.196 |
| Display Name |
Molecular Partners |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,741,345,140 |
| Earnings Call Timestamp Start |
1,741,345,140 |
| Earnings Timestamp |
1,787,661,000 |
| Earnings Timestamp End |
1,787,661,000 |
| Earnings Timestamp Start |
1,787,661,000 |
| Ebitda |
-50,850,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-1.406 |
| Enterprise Value |
71,478,640 |
| Eps Current Year |
-1.11065 |
| Eps Forward |
-0.1642892 |
| Eps Trailing Twelve Months |
-1.71 |
| Esg Populated |
0 |
| Exchange |
NMS |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
41 44 755 77 07 |
| Fifty Day Average |
4.11514 |
| Fifty Day Average Change |
-0.55514 |
| Fifty Day Average Change Percent |
-0.13490185 |
| Fifty Two Week Change Percent |
-6.561679 |
| Fifty Two Week High |
5.36 |
| Fifty Two Week High Change |
-1.8000002 |
| Fifty Two Week High Change Percent |
-0.3358209 |
| Fifty Two Week Low |
3.52 |
| Fifty Two Week Low Change |
0.03999996 |
| Fifty Two Week Low Change Percent |
0.0113636255 |
| Fifty Two Week Range |
3.52 - 5.36 |
| Financial Currency |
CHF |
| First Trade Date Milliseconds |
1,623,850,200,000 |
| Float Shares |
20,712,408 |
| Forward Eps |
-0.1642892 |
| Forward P E |
-21.669104 |
| Free Cashflow |
-27,040,624 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
134 |
| Fullday Change |
0.006599903 |
| Fullday Change Percent |
0.18573487 |
| Fullday Price |
3.56 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Gross Profits |
-35,566,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.093830004 |
| Implied Shares Outstanding |
38,305,237 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-06-16 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. |
| Long Name |
Molecular Partners AG |
| Market |
us_market |
| Market Cap |
136,366,640 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_32677064 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-51,187,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
156,775,457 |
| Number Of Analyst Opinions |
5 |
| Open |
3.71 |
| Operating Cashflow |
-46,113,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
41 44 755 77 00 |
| Previous Close |
3.5334 |
| Price Eps Current Year |
-3.2053304 |
| Price Hint |
4 |
| Price To Book |
1.9288056 |
| Profit Margins |
0.0 |
| Quick Ratio |
7.054 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.026599884 |
| Regular Market Change Percent |
0.7528127 |
| Regular Market Day High |
3.71 |
| Regular Market Day Low |
3.56 |
| Regular Market Day Range |
3.56 - 3.71 |
| Regular Market Open |
3.71 |
| Regular Market Previous Close |
3.5334 |
| Regular Market Price |
3.56 |
| Regular Market Time |
1,792,180,800 |
| Regular Market Volume |
680 |
| Return On Assets |
-0.32275 |
| Return On Equity |
-0.61967 |
| Sand P52 Week Change |
0.13723719 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
38,305,237 |
| Shares Percent Shares Out |
0.0 |
| Shares Short |
247 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
219 |
| Short Name |
Molecular Partners AG |
| Short Percent Of Float |
0.0 |
| Short Ratio |
0.22 |
| Source Interval |
15 |
| Symbol |
MOLN |
| Target High Price |
16.573378 |
| Target Low Price |
3.6801398 |
| Target Mean Price |
10.491615 |
| Target Median Price |
11.698498 |
| Total Cash |
67,930,000 |
| Total Cash Per Share |
1.773 |
| Total Debt |
3,042,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.71 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
4.199525 |
| Two Hundred Day Average Change |
-0.63952494 |
| Two Hundred Day Average Change Percent |
-0.15228507 |
| Type Disp |
Equity |
| Volume |
680 |
| Website |
https://www.molecularpartners.com |
| Zip |
8,952 |